4015.SR
4015.SR
SA15QGU1UNH6
Jamjoom Pharmaceuticals Factory
Loading chart...

Company Profile

Jamjoom Pharmaceuticals Factory Company, together with its subsidiaries, engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally. It provides human medicines; nutraceuticals; antibiotics; general analgesics; medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, and ulcer and acidity; treatment of various skin infections and cancer diseases; and eye drops, and ointments and cosmeceuticals. The company also offers ophthalmic solutions, dermatology products, cardiovascular health, consumer health, respiratory health, gastrointestinal health, endocrinology and diabetes care, central nervous system, and pain and inflammation pharmaceutical products. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.

Related stocks

2230.SR
2230.SR • Saudi Arabia
Saudi Chemical Co.
7.22 SAR
1.62B USD 1Y +0.6%
2070.SR
2070.SR • Saudi Arabia
Saudi Pharmaceutical Industries
30.46 SAR
968.19M USD 1Y +2.8%
4016.SR
4016.SR • Saudi Arabia
Middle East Pharmaceutical Indu
63.25 SAR
589.55M USD 1Y -17.4%
APN.JO
APN.JO • South Africa
Aspen Pharmacare Hldgs Ltd
15,826 ZAc
4.15B USD 1Y +65.2%
ECILC.IS
ECILC.IS • Türkiye
ECZACIBASI ILAC
62.3 TRY
866.66M USD 1Y -32%
HCM
HCM • Hong Kong SAR China
HUTCHMED (China) Limited
14.1 USD
2.45B USD 1Y -16.6%
HCM.L
HCM.L • Hong Kong SAR China
HUTCHMED (CHINA) LIMITED ORD US
203 GBp
2.33B USD 1Y -11.8%
PBH
PBH • United States
Prestige Consumer Healthcare In
48.23 USD
2.28B USD 1Y -24.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
29.8% p.a.
Max Drawdown (3Y)
-37.6%
Sharpe Ratio (3Y)
0.11
Beta Factor
0.35
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende